Henry Schein's Brasseler USA Partners with Biolase MG for Exclusive YSGG Laser Technology in Endodontics

Reuters
23 Jul
Henry Schein's Brasseler USA Partners with <a href="https://laohu8.com/S/BIOL">Biolase</a> MG for Exclusive YSGG Laser Technology in Endodontics

Brasseler USA, a prominent player in endodontic solutions, has entered into a strategic partnership with Biolase MG, becoming the exclusive US provider of the Biolase YSGG advanced laser technology. This collaboration aims to enhance endodontic treatments through the EdgePro laser, which offers effective cleaning and disinfection, improving patient outcomes and clinical efficiency. This partnership is a significant step in Brasseler's commitment to providing a premium endodontic portfolio and follows the launch of their Endodontist Specialty Sales Consultant team. The new alliance is expected to deliver comprehensive support and innovative solutions to clinicians, elevating clinical care and optimizing practice success.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Henry Schein Inc. published the original content used to generate this news brief on July 22, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10